Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label updated from v3.5.3 to v3.5.4, indicating an administrative update to the page version. This change does not alter substantive study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision badge on the page now shows v3.5.3, replacing the previous v3.5.2. This represents a minor page update with no changes to the study details or results.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The government funding lapse notice and the earlier Revision: v3.4.1 text have been removed.SummaryDifference0.5%

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.